In-silico characterization of the effects of phosphorylated tyrosines 86 and 106 on structure and binding of MAL: insight into hyperinflammatory response to infection by the human malaria parasites

References

• Serhan CN, Ward PA, Gilroy DW. Fundamentals of Inflammation. Cambridge: Cambridge University Press, 2010.
   Google Scholar
• World Health Organization. WHO Malaria Fact Sheet No.94. Available at: http://www.who.int/mediacentre/factsheets/fs094/en/index.html (Accessed April 2010).
   Google Scholar
• Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002, 415, 673–679.
   PubMed Web of Science ®Google Scholar
• Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987, 81, 478–486.
   PubMed Web of Science ®Google Scholar
• Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, Medana IM, Miu J, Ball HJ. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006, 36, 569–582.
   PubMed Web of Science ®Google Scholar
• Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 2008, 7, 83.
   PubMed Web of Science ®Google Scholar
• Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O’Neill LA, Hill AV. A MAL functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007, 39, 523–528.
   PubMed Web of Science ®Google Scholar
• Swiss Institute of Bioinformatics. Swiss-Prot Protein Knowledge Base. Available at: http://www.expasy.ch/sprot/ (Accessed 25 February 2010).
   Google Scholar
• Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420, 324–329.
   PubMed Web of Science ®Google Scholar
• Doyle SL, O’Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006, 72, 1102–1113.
   PubMed Web of Science ®Google Scholar
• Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420, 329–333.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Takaesu G, Yoshimura A. MAL-function of TLRs by SOCS. Nat Immunol 2006, 7, 123–124.
   PubMed Web of Science ®Google Scholar
• Toshchakov VY, Fenton MJ, Vogel SN. Cutting Edge: Differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J Immunol 2007, 178, 2655–2660.
   PubMed Web of Science ®Google Scholar
• Loiarro M, Sette C, Gallo G, Ciacci A, Fantò N, Mastroianni D, Carminati P, Ruggiero V. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B. J Biol Chem 2005, 280, 15809–15814.
   PubMed Web of Science ®Google Scholar
• Dunne A, Ejdeback M, Ludidi PL, O’Neill LA, Gay NJ. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors MAL and MyD88. J Biol Chem 2003, 278, 41443–41451.
   PubMed Web of Science ®Google Scholar
• Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986, 234, 364–368.
   PubMed Web of Science ®Google Scholar
• Piao W, Song C, Chen H, Wahl LM, Fitzgerald KA, O’Neill LA, Medvedev AE. Tyrosine phosphorylation of MyD88 adapter-like (MAL) is critical for signal transduction and blocked in endotoxin tolerance. J Biol Chem 2008, 283, 3109–3119.
   PubMed Web of Science ®Google Scholar
• Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, Mohamed AJ, Nore BF, Vihinen M, Smith CI. Bruton’s tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev 2005, 203, 200–215.
   PubMed Web of Science ®Google Scholar
• Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, Wietek C, Walch E, Wirth T, O’Neill LA. Bruton’s tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem 2003, 278, 26258–26264.
   PubMed Web of Science ®Google Scholar
• Ubersax JA, Ferrell JE Jr. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 2007, 8, 530–541.
   PubMed Web of Science ®Google Scholar
• Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O’Neill LA, Hertzog PJ. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating MAL degradation. Nat Immunol 2006, 7, 148–155.
   PubMed Web of Science ®Google Scholar
• Gray P, Dunne A, Brikos C, Jefferies CA, Doyle SL, O’Neill LA. MyD88 adapter-like (MAL) is phosphorylated by Bruton’s tyrosine kinase during TLR2 and TLR4 signal transduction. J Biol Chem 2006, 281, 10489–10495.
   PubMed Web of Science ®Google Scholar
• Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25, 3389–3402.
   PubMed Web of Science ®Google Scholar
• Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C. The Protein Data Bank. Acta Crystallogr D Biol Crystallogr 2002, 58, 899–907.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, Kimura T, Hiroaki H, Kondo N, Shirakawa M. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci USA 2009, 106, 10260–10265.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000, 408, 111–115.
   PubMed Web of Science ®Google Scholar
• Notredame C, Higgins DG, Heringa J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000, 302, 205–217.
   PubMed Web of Science ®Google Scholar
• Armougom F, Moretti S, Poirot O, Audic S, Dumas P, Schaeli B, Keduas V, Notredame C. Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee. Nucleic Acids Res 2006, 34, W604–W608.
   PubMed Web of Science ®Google Scholar
• Thompson JD, Thierry JC, Poch O. RASCAL: rapid scanning and correction of multiple sequence alignments. Bioinformatics 2003, 19, 1155–1161.
   PubMedGoogle Scholar
• Plewniak F, Bianchetti L, Brelivet Y, Carles A, Chalmel F, Lecompte O, Mochel T, Moulinier L, Muller A, Muller J, Prigent V, Ripp R, Thierry JC, Thompson JD, Wicker N, Poch O. PipeAlign: A new toolkit for protein family analysis. Nucleic Acids Res 2003, 31, 3829–3832.
   PubMed Web of Science ®Google Scholar
• Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000, 29, 291–325.
   PubMedGoogle Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234, 779–815.
   PubMed Web of Science ®Google Scholar
• Kelley LA, Gardner SP, Sutcliffe MJ. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng 1996, 9, 1063–1065.
   PubMedGoogle Scholar
• Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 1993, 2, 1511–1519.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983, 4, 187–217.
   Web of Science ®Google Scholar
• Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem 2005, 26, 1781–1802.
   PubMed Web of Science ®Google Scholar
• MacKerell AD, Bashford D, Bellott RL, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998, 102, 3586–3616.
   PubMed Web of Science ®Google Scholar
• Feng M-H Philippopoulos, M, MacKerell AD, Lim C. Structural characterization of the phosphotyrosine binding region of a high-affinity SH2 domain-phosphopeptide complex by molecular dynamics simulation and chemical shift calculations. J Am Chem Soc 1996, 118, 11265–11277.
   Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983, 79, 926–935.
   Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996, 14, 33–8, 27–8.
   PubMed Web of Science ®Google Scholar
• Bergamin E, Wu J, Hubbard SR. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. Structure 2006, 14, 1285–1292.
   PubMed Web of Science ®Google Scholar
• Bullock AN, Debreczeni JE, Edwards AM, Sundström M, Knapp S. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc Natl Acad Sci USA 2006, 103, 7637–7642.
   PubMed Web of Science ®Google Scholar
• Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins 2003, 52, 80–87.
   PubMed Web of Science ®Google Scholar
• Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25, 1189–1191.
   PubMed Web of Science ®Google Scholar
• DeLano WL. The PyMOL molecular graphics system. (Software) San Carlos, CA, USA. DeLano Scientific, 2002.
   Google Scholar
• Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PDBViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18, 2714–2723.
   PubMed Web of Science ®Google Scholar
• Rocchia W, Alexov E, Honig B. Extending the applicability of the nonlinear Poisson–Boltzmann equation: multiple dielectric constants and multivalent ions. J Phys Chem B 2001, 105, 6507–6514.
   Web of Science ®Google Scholar
• Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun 1995, 91, 43–56.
   Web of Science ®Google Scholar
• Sawyer TK. Src homology-2 domains: structure, mechanisms, and drug discovery. Biopolymers 1998, 47, 243–261.
   Google Scholar
• Tong L, Warren TC, King J, Betageri R, Rose J, Jakes S. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution. J Mol Biol 1996, 256, 601–610.
   PubMed Web of Science ®Google Scholar
• Gilson MK, Honig B. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 1988, 4, 7–18.
   PubMed Web of Science ®Google Scholar
• Nicholls A, Honig B. A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson–Boltzmann equation. J Comput Chem 1991, 12, 435–445.
   Web of Science ®Google Scholar
• Imgenex. TIRAP Inhibitory Peptide Set Protein Design. Available at: http://www.imgenex.com/get_details.php?catalog_no=IMG-2006-1 (Accessed 25 February 2010).
   Google Scholar
• Imgenex. MyD88 Homodimerization Inhibitory Peptide Set. Available at: http://www.imgenex.com/get_details.php?catalog_no=IMG-2005-1 (Accessed 25 February 2010).
   Google Scholar
• Nyman T, Stenmark P, Flodin S, Johansson I, Hammarström M, Nordlund P. The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem 2008, 283, 11861–11865.
   PubMed Web of Science ®Google Scholar
• Tao X, Xu Y, Zheng Y, Beg AA, Tong L. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem Biophys Res Commun 2002, 299, 216–221.
   PubMed Web of Science ®Google Scholar
• Slack JL, Schooley K, Bonnert TP, Mitcham JL, Qwarnstrom EE, Sims JE, Dower SK. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J Biol Chem 2000, 275, 4670–4678.
   PubMed Web of Science ®Google Scholar